Q3 2023 Holdings
Filed 2023-11-14 | 8 holdings | $352.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rayzebio Inc | COM | 75525N107 | $114.5M | 5,158,162 | 32.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $89.0M | 4,264,672 | 25.2% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $46.6M | 9,699,925 | 13.2% |
| Acelyrin Inc | COM | 00445A100 | $39.2M | 3,852,470 | 11.1% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $33.9M | 1,035,396 | 9.6% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $26.4M | 758,800 | 7.5% |
| Elevation Oncology Inc | COM | 28623U101 | $1.9M | 2,914,255 | 0.5% |
| Impel Pharmaceuticals Inc | COM | 45258K109 | $1.2M | 2,759,791 | 0.3% |